BSE filing, NSE: VIVANZA. Summary written from the filing by ALFA Finder's alert engine.
Vivanza Biosciences Ltd: key numbers
- Share price
- ₹1.54
- Market cap
- ₹6.16 Cr
- Revenue (annual)
- ₹115.9 Cr
- Net profit (annual)
- ₹0.39 Cr
- P/E (TTM)
- 13.6×Sector 45.9×
- Promoter holding
- 20.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vivanza Biosciences Ltd
All →Vivanza Biosciences Board Meeting Date
Vivanza Biosciences has scheduled a Board meeting on November 3, 2026 to approve unaudited Q2 and H1 FY27 financial results. No other material agenda items are listed.
Vivanza Biosciences Other Announcement
Vivanza Biosciences Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Vivanza Biosciences Annual General Meeting
Vivanza Biosciences has convened its 44th AGM on September 11, 2026 via VC/OAVM. Nine agenda items cover financial statements, director appointments, and borrowing limit approvals.
Vivanza Biosciences Annual Report
Vivanza Biosciences Limited has scheduled its 44th Annual General Meeting for September 11, 2026. The company also released its full Annual Report for the financial year 2025-26.
Vivanza Biosciences Board Meeting Outcome
Vivanza Biosciences approved its annual reports, the convening of the 44th AGM, and various procedural resolutions including borrowing limits and related party transactions for upcoming periods.
Vivanza Biosciences Board Meeting Date
Vivanza Biosciences has scheduled a board meeting for August 17, 2026, to discuss the AGM, financial reports, and various corporate authorizations under the Companies Act.
Other debt & borrowing announcements
All →Signatureglobal (India) Debt & Borrowing
Signatureglobal disclosed corporate guarantees issued by its wholly owned subsidiaries to IndusInd Bank facilities. The guarantees secure Rs 150 crore, Rs 250 crore and Rs 398.3 crore of term loan facilities.
LIC Housing Finance Debt & Borrowing
LIC Housing Finance reported a 1.24x security cover on listed secured NCDs. It is a Regulation 54 certificate with no new event amount.
Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Blue Coast Hotels Debt & Borrowing: ₹14.52 Cr
Blue Coast Hotels defaulted on Rs 14.52 crore principal and dividend on redeemable preference shares. Default occurred 30 October 2026, affecting unlisted debt holders.
- Value
- ₹14.52 Cr
Sammaan Capital Debt & Borrowing: ₹0.88 Cr
Sammaan Capital paid Rs.0.88 Crore of monthly interest on secured NCDs on October 30, 2026, ahead of the November 1 due date.
- Value
- ₹0.88 Cr
Sammaan Capital Debt & Borrowing: ₹0.58 Cr
Sammaan Capital certifies timely payment of Rs 0.58 crore interest on listed public-issue NCDs. The payment covers seven ISINs, with interest paid on October 30, 2026.
- Value
- ₹0.58 Cr